For emerging therapies like the Symplicity Spyral RDN system, which is used during the Symplicity™ blood pressure procedure, it can take time to establish reimbursement. The following coding, coverage, and payment resources are available to guide providers through the reimbursement process, including prior authorization and appeals. If you have any questions, please email us.



Coding, coverage, and payment resources

We will continue to update this page with the latest resources as they become available.

If you'd like to receive the latest reimbursement updates directly in your email, please fill out the form on the bottom of this page.

Expand All

Coverage resources

Request additional reimbursement resources and sign up for updates.

By submitting this form, you agree to receive the reimbursement documents specified above directly via email from a Medtronic team member. In this form, you can also opt in to receive emails regarding reimbursement updates for the Symplicity procedure, including the Symplicity Spyral RDN system.

* Indicates a required field.

Medtronic provides this information for your convenience only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice due to frequently changing laws, rules, and regulations. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided.

Medtronic makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, other payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage and payment policies.

These resources provide assistance for FDA approved or cleared indications. Where reimbursement is sought for use of a product that may be inconsistent with, or not expressly specified in, the FDA cleared or approved labeling (e.g., instructions for use, operator’s manual or package insert), consult with your billing advisors or payers on handling such billing issues. Some payers may have policies that make it inappropriate to submit claims for such items or related service.  

Connect with us.

If you have questions regarding reimbursement for the Symplicity procedure, including the Symplicity Spyral RDN system, please contact our customer support team.